statistiche ricercatore

Continente	#
NA - Nord America	696
EU - Europa	621
AS - Asia	328
SA - Sud America	52
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
Totale	1.711

Nazione	#
US - Stati Uniti d'America	683
RU - Federazione Russa	268
CN - Cina	134
SG - Singapore	125
GB - Regno Unito	105
SE - Svezia	53
FI - Finlandia	51
BR - Brasile	43
FR - Francia	30
DE - Germania	29
IT - Italia	26
IE - Irlanda	25
HK - Hong Kong	23
VN - Vietnam	23
BE - Belgio	9
CA - Canada	8
TR - Turchia	7
UA - Ucraina	7
PL - Polonia	4
ZA - Sudafrica	4
EU - Europa	3
IN - India	3
KR - Corea	3
MX - Messico	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
AT - Austria	2
AU - Australia	2
BD - Bangladesh	2
IL - Israele	2
NL - Olanda	2
VE - Venezuela	2
BJ - Benin	1
BO - Bolivia	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EC - Ecuador	1
EG - Egitto	1
ES - Italia	1
GR - Grecia	1
HU - Ungheria	1
ID - Indonesia	1
JM - Giamaica	1
JP - Giappone	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
NO - Norvegia	1
RO - Romania	1
RS - Serbia	1
TG - Togo	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.711

Nome	#
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study	189
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.	183
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis	180
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up?	167
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report.	160
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.	150
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions	150
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.	148
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.	147
Is platelet gel safe enough for neutropenic patients?	116
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080)	97
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies	37
Totale	1.724

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	47	0	0	0	0	10	11	3	2	2	4	8	7
2021/2022	111	9	42	3	16	1	2	4	3	2	3	8	18
2022/2023	229	15	30	18	55	8	51	1	22	18	2	6	3
2023/2024	135	1	15	11	9	23	27	3	6	0	16	16	8
2024/2025	237	11	15	17	32	12	13	16	9	33	12	21	46
2025/2026	584	61	26	79	177	241	0	0	0	0	0	0	0
Totale													1.724

CATALOGO DEI PRODOTTI DELLA RICERCA